Quantitative metrics of net proliferation and invasion link biological aggressiveness assessed by MRI with hypoxia assessed by FMISO-PET in newly diagnosed glioblastomas - sprookjes - yvandenbroek - TriplyDB

Quantitative metrics of net proliferation and invasion link biological aggressiveness assessed by MRI with hypoxia assessed by FMISO-PET in newly diagnosed glioblastomas

Quantitative metrics of net proliferation and invasion link biological aggressiveness assessed by MRI with hypoxia assessed by FMISO-PET in newly diagnosed glioblastomas

http://www.wikidata.org/entity/Q37140172

about

Malignant gliomas: current perspectives in diagnosis, treatment, and early response assessment using advanced quantitative imaging methods Modern brain tumor imaging Biphasic modeling of brain tumor biomechanics and response to radiation treatment Patient-specific mathematical neuro-oncology: using a simple proliferation and invasion tumor model to inform clinical practice Parameterizing the Logistic Model of Tumor Growth by DW-MRI and DCE-MRI Data to Predict Treatment Response and Changes in Breast Cancer Cellularity during Neoadjuvant Chemotherapy.Integrating Imaging Data into Predictive Biomathematical and Biophysical Models of Cancer Imaging biomarkers in primary brain tumours.The integration of quantitative multi-modality imaging data into mathematical models of tumors.Current progress in patient-specific modeling.Invasion and proliferation kinetics in enhancing gliomas predict IDH1 mutation status.Modeling tumor growth and treatment response based on quantitative imaging data Mathematical Analysis of Glioma Growth in a Murine Model.Uncertainty in the translation of preclinical experiments to clinical trials. Why do most phase III clinical trials fail?Nonlinear modelling of cancer: bridging the gap between cells and tumours Gene therapy enhances chemotherapy tolerance and efficacy in glioblastoma patients Receptors for hyaluronic acid and poliovirus: a combinatorial role in glioma invasion?Imaging hypoxia in gliomas.Mathematical Oncology: How Are the Mathematical and Physical Sciences Contributing to the War on Breast Cancer?Patient-specific metrics of invasiveness reveal significant prognostic benefit of resection in a predictable subset of gliomas Discriminating survival outcomes in patients with glioblastoma using a simulation-based, patient-specific response metric Hybrid models of tumor growth.Toward patient-specific, biologically optimized radiation therapy plans for the treatment of glioblastoma.Glial progenitor cell recruitment drives aggressive glioma growth: mathematical and experimental modelling.Predicting the Response of Breast Cancer to Neoadjuvant Therapy Using a Mechanically Coupled Reaction-Diffusion Model.ST3GAL1-Associated Transcriptomic Program in Glioblastoma Tumor Growth, Invasion, and Prognosis.From patient-specific mathematical neuro-oncology to precision medicine Modeling Tumor-Associated Edema in Gliomas during Anti-Angiogenic Therapy and Its Impact on Imageable Tumor Bevacizumab in high-grade gliomas: a review of its uses, toxicity assessment, and future treatment challenges.Microcirculatory fraction (MCF(I)) as a potential imaging marker for tumor heterogeneity in breast cancer.Quantitative multimodality imaging in cancer research and therapy Mathematical modelling of spatio-temporal glioma evolution Response classification based on a minimal model of glioblastoma growth is prognostic for clinical outcomes and distinguishes progression from pseudoprogression.A mechanically coupled reaction-diffusion model for predicting the response of breast tumors to neoadjuvant chemotherapy.Current trends in mathematical modeling of tumor-microenvironment interactions: a survey of tools and applications.Cellular modeling of cancer invasion: integration of in silico and in vitro approaches Tumor hypoxia: a new PET imaging biomarker in clinical oncology.Novel positron emission tomography radiotracers in brain tumor imaging.Quantification of Tumor Hypoxic Fractions Using Positron Emission Tomography with [18F]Fluoromisonidazole ([18F]FMISO) Kinetic Analysis and Invasive Oxygen Measurements.Image based modeling of tumor growth.Inhibition of monocarboxylate transporter-4 depletes stem-like glioblastoma cells and inhibits HIF transcriptional response in a lactate-independent manner.

P2860

Q26853516-EAB5123D-197B-475E-9331-EFCD0AF89026 Q27002344-6187DFC8-1EDA-42D0-AE70-E9A259F80AFF Q27310114-0A5E4ACE-7AF7-458A-A432-84B0F3723B24 Q28083949-F3987BDA-3884-486E-A767-229561ED2C45 Q30639288-C9A8BB26-9DA4-4859-AB40-8A12C56F982A Q30659261-AA62F094-FB5D-41DC-85A4-ECF34EB3F02D Q30880129-E741ED50-C834-4B90-A5FA-96F3CDB61E10 Q33550040-C85F69FE-92FC-4173-BA54-65647EAC21EF Q33605053-86C22D34-5D82-46A0-A65D-1D3F019AAA49 Q33616627-2447D52B-3140-4054-9ACC-309EBE101B30 Q33623804-6C9C51BF-65FC-4ED9-96A3-05C161436B28 Q33747076-B3BF5A38-0762-4E5E-AE16-602B97A23EDB Q33828102-77452C89-B774-467B-947D-A70F2C97075B Q34090411-92E2504C-C773-4162-A793-0B10F72D70B5 Q34117487-6CBD3AD0-6E73-4AAE-989B-3F6AB5CBE8B5 Q34170169-4B6E667C-6F8C-4E80-8D63-912183DE31E8 Q34203937-0EBD5373-E9C2-44EC-91CD-B83E92934ADE Q34329939-7EEA14DF-CB82-4D79-A90D-94D28510377E Q34414528-012D0AAA-B170-43B4-A6DD-8C2FB30C0391 Q34570841-A959F0FF-5D67-4B76-81DD-34F0AD577635 Q34676158-CBE986C6-2D4D-4ACB-88C5-687AC9382664 Q35050427-F2067798-BC63-4FF3-A4F4-2A11EE1B100B Q36065454-FF154AF4-AD69-4A76-A129-03DA9DFAD8F4 Q36296828-BF1B204B-A205-423C-A31F-7BEA4B53507F Q36585186-FD18B637-16E8-4ABF-8091-EC04E63149D5 Q36733380-53EE0216-EC04-4845-8AFF-E8C1EEF422E0 Q36739473-921208AE-C0AD-4F9A-9FFB-5111C36D278A Q36787777-9085966D-2EEA-450F-85B9-8144AB607A8A Q36821142-20DCA57E-06C2-466B-BBA6-C3E036A253CC Q37007810-59B21A55-47E6-4C91-A1CB-C7176D166E57 Q37071679-FC31C0BB-57D1-4E43-95B0-6C177ABF2EDC Q37088426-C00E0BA4-0B76-4504-AA45-56152029D840 Q37218930-4E033DE8-6F5D-4DA9-8287-CC948CF85E24 Q37734713-C17C2E18-974A-40D3-BC0D-0C8E877FF525 Q37861621-07C49769-4A5D-4D98-941C-AEB0E4FC1FA6 Q38411275-49243B15-361B-4C55-B083-F827671A4954 Q38670632-497BE454-214A-4FF8-B1F2-D425E48BC1E8 Q38837272-AE788FD2-3F94-4524-96B8-D0E8063F4E3F Q38946715-D9BEB259-5E43-40C1-81F5-A83D5E12F480 Q39090175-A9E8D09D-1D58-401C-BB37-75720AD511AE

P2860

Quantitative metrics of net proliferation and invasion link biological aggressiveness assessed by MRI with hypoxia assessed by FMISO-PET in newly diagnosed glioblastomas

http://www.wikidata.org/entity/Q37140172

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 14 April 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Quantitative metrics of net pr ...... newly diagnosed glioblastomas

@en

Quantitative metrics of net pr ...... newly diagnosed glioblastomas.

@nl

type

label

Quantitative metrics of net pr ...... newly diagnosed glioblastomas

@en

Quantitative metrics of net pr ...... newly diagnosed glioblastomas.

@nl

prefLabel

Quantitative metrics of net pr ...... newly diagnosed glioblastomas

@en

Quantitative metrics of net pr ...... newly diagnosed glioblastomas.

@nl

P1433

Q37140172-8617E753-5891-42DE-8E45-EF6F715A65E0

P1476

Q37140172-B11B7485-D826-46F9-8F26-1AC9F308DBD3

P2093

Q37140172-42B8D8DB-0CF0-41ED-9EA6-FE4745C96EEA

Q37140172-68FDED15-83F1-40BC-965A-C60EB1E2E600

Q37140172-703F7657-EC9D-428C-BC8C-802199AF907A

Q37140172-70946568-6635-45F2-9EA7-90592467B7EF

Q37140172-9386B77D-0123-49A9-A02B-081F881B5528

Q37140172-BFFF4B57-E8CF-4B85-9A57-5C15C526F388

Q37140172-D14FCB4F-AC84-4E50-B1E9-4D99A703B6A4

P2860

Q37140172-04910B66-78DB-4811-91C1-1C5AA43A8CBD

Q37140172-0A17D7EB-964E-456B-A795-B58FC7A57544

Q37140172-105E028F-6311-42C4-A725-0C237ECB2BFA

Q37140172-3444F604-6C96-4881-B05F-7F1ADE75D67A

Q37140172-3478B306-1991-4C1D-8170-61DDCF9E5875

Q37140172-34E64AEA-D8F3-48DE-928C-5EAB49F07849

Q37140172-3AF5DC67-1DF4-4F63-B429-AB515D6939C6

Q37140172-41A6F7C9-6235-4AF9-81C5-541C9FDA7B7B

Q37140172-61B1B3C0-1B4C-4768-B88B-12687F180AC0

Q37140172-650ED71F-04CE-425D-890A-10050156C877

P304

Q37140172-03118502-E2A5-4819-9C8A-2C684B7B912B

P31

Q37140172-30989F19-069F-4F4E-B06B-C5C9B6C5DBBD

P356

Q37140172-4A186286-A0BB-40E6-B671-FC8F4C9F58F9

P407

Q37140172-C2FB42D9-9FE3-41D0-BCC5-756FB57E910F

P433

Q37140172-F91066F0-037C-463F-971E-AC49EC8A9CEF

P478

Q37140172-EF7EEEC9-A2A0-44BA-BA52-6093F660A535

P50

Q37140172-A459C458-486D-4F3C-AB22-86225762411D

Q37140172-FB75493C-4259-466A-95B0-01E24FFAE8B8

P577

Q37140172-8123D83A-9B46-4852-A5AA-D496F6A69EB2

P5875

Q37140172-E7B175B3-C39F-44CD-9C47-658E6E300668

P698

Q37140172-05A39B6A-276E-46F3-850A-7C46C85ADEE4

P921

Q37140172-1919E426-BABE-4374-9561-34F18CCF5C84

P932

Q37140172-ACD9E43B-049F-476E-9D99-9B17E88396B4

P356

0008-5472.CAN-08-3884

P1433

Cancer Research

P1476

Quantitative metrics of net pr ...... newly diagnosed glioblastomas

@en

P2093

Alexander M Spence

http://www.w3.org/2001/XMLSchema#string

Ellsworth C Alvord

http://www.w3.org/2001/XMLSchema#string

Gargi Chakraborty

http://www.w3.org/2001/XMLSchema#string

Jennifer Hadley

http://www.w3.org/2001/XMLSchema#string

Kenneth A Krohn

http://www.w3.org/2001/XMLSchema#string

Mark Muzi

http://www.w3.org/2001/XMLSchema#string

Mindy D Szeto

http://www.w3.org/2001/XMLSchema#string

P2860

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

The WHO classification of tumors of the nervous system.

PET: the merging of biology and imaging into molecular imaging.

18F-labeled radiopharmaceuticals for PET in oncology, excluding FDG.

Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation.

Complementary but distinct roles for MRI and 18F-fluoromisonidazole PET in the assessment of human glioblastomas.

Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging.

Primary and secondary glioblastomas: from concept to clinical diagnosis

Chemoradiotherapy in malignant glioma: standard of care and future directions.

Regional hypoxia in glioblastoma multiforme quantified with [18F]fluoromisonidazole positron emission tomography before radiotherapy: correlation with time to progression and survival

P304

4502-4509

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-08-3884

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

69

http://www.w3.org/2001/XMLSchema#string

P50

Kristin R Swanson

P577

2009-04-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24277946

http://www.w3.org/2001/XMLSchema#string

P698

19366800

http://www.w3.org/2001/XMLSchema#string

P921

P932

3760276

http://www.w3.org/2001/XMLSchema#string